Další formáty:
BibTeX
LaTeX
RIS
@article{1317915,
author = {Janíková, Andrea},
article_location = {Oxon},
article_number = {10},
doi = {http://dx.doi.org/10.3109/10428194.2015.1049172},
keywords = {Radiotherapy; follicular lymphoma},
language = {eng},
issn = {1042-8194},
journal = {Leukemia and Lymphoma},
title = {Radiotherapy in early stage follicular lymphoma: is it really the gold standard?},
volume = {56},
year = {2015}
}
TY - JOUR
ID - 1317915
AU - Janíková, Andrea
PY - 2015
TI - Radiotherapy in early stage follicular lymphoma: is it really the gold standard?
JF - Leukemia and Lymphoma
VL - 56
IS - 10
SP - 2999-3000
EP - 2999-3000
PB - Taylor & Francis
SN - 10428194
KW - Radiotherapy
KW - follicular lymphoma
N2 - Major changes have occurred during the last few years in the management of follicular lymphoma (FL), leading to substantial improvement in prognosis and overall survival. One of the turning points was the introduction of rituximab (R). Th is monoclonal antibody is now the cornerstone of therapy for advanced disease and is now a standard part of treatment. However, for the 25 – 30% patients with localized disease (stage I or II), involved-fi eld radiotherapy (IFRT) remains the gold standard [1]. We can indeed ask if this treatment modality is truly the gold standard?
ER -
JANÍKOVÁ, Andrea. Radiotherapy in early stage follicular lymphoma: is it really the gold standard? \textit{Leukemia and Lymphoma}. Oxon: Taylor \&{} Francis, 2015, roč.~56, č.~10, s.~2999-3000. ISSN~1042-8194. Dostupné z: https://dx.doi.org/10.3109/10428194.2015.1049172.
|
